Health : Page 41
March 1, 2023
People with children aged six months to four years are advised that Canada’s current supply of the infant Moderna mRNA COVID-19 vaccine expires on March 8, 2023.
February 28, 2023
Brazil on Monday began to apply a bivalent vaccine against the novel coronavirus disease (COVID-19), starting with vulnerable groups including people over 70 years of age, the Health Ministry said.
February 28, 2023
The National Comprehensive Cancer Network, a not-for-profit alliance of leading United States cancer centers, announced a new collaboration with the Institute of Hematology and Transfusion Medicine in Poland (IHIT), and the Alliance For Innovation—Polish-American Foundation (AFI).
February 27, 2023
A research team led by the University of Technology Sydney (UTS) has developed a new device to detect and analyze cancer cells from blood samples, which can help doctors to monitor treatment progress without conducting invasive biopsy surgeries.
February 26, 2023
The Ministry of Health (MoH) has officially added COVID-19 to the list of occupational diseases, meaning that certain employees will be able to make social insurance payment claims if they contracted the coronavirus.
February 25, 2023
Spain has detected its first suspected case of Marburg disease, a deadly infectious disease that has led to the quarantining of more than 200 people in Equatorial Guinea, health authorities in the Spanish region of the Valencia said on Saturday.
February 25, 2023
Pfizer and BioNTech have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as a primary series and booster dose(s) for individuals 12 years of age and older.
February 24, 2023
Merck and Ridgeback Biotherapeutics announced today that a group of medical experts in the EU has declined to recommend marketing authorization for the oral COVID-19 pill Lagevrio (molnupiravir) for adults.
February 22, 2023
Moderna announced that Health Canada has authorized the use of its Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.214 (SpikevaxBivalent Original/Omicron) in children and adolescents 6 to 17 years of age.
February 22, 2023
National surveillance data shows laboratory reports of the virus are 66% higher than the average at this time of year.
February 22, 2023
Postmortems of 11 patients who died in Japan after contracting COVID-19 in 2021 found that an infectious viral load remained in the nasopharynx and lungs of over half, with one having been dead for 13 days, a health ministry study showed Monday.
February 21, 2023
Pharming Group announces that the first patient has been enrolled in its Phase III clinical trial (NCT05438407) evaluating the investigational drug leniolisib, an oral, selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, in children with activated phosphoinositide 3-kinase delta syndrome (APDS).